Pushing The Limits

In this enlightening episode, we sit down with Laura Yecies to discuss Osteoboost, the first and only FDA-cleared, drug-free prescription medical device designed to treat osteopenia in postmenopausal women. Yecies shares insights into the clinical research behind Osteoboost, its development inspired by NASA-funded studies, and the importance of proactive bone health management. Key Topics Covered: The Innovation Behind Osteoboost: Understanding how precision vibration therapy targets the spine and hips to reduce bone density and strength loss. (Osteoboost) Clinical Efficacy: Discussing the results from a double-blind, placebo-controlled clinical trial showing up to an 85% reduction in spine bone density loss and an 83% reduction in bone strength loss among consistent users. (MedicalEconomics) Importance of Early Intervention: Exploring why addressing bone health before the onset of osteoporosis is crucial, especially for postmenopausal women. User Experience: Highlighting the ease of incorporating Ost